(Q44437048)

3 December 2017

title

Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit (English)

1 reference

3 December 2017

1 reference

1 reference

Prabhu Rajagopalan

1 reference

3 December 2017

Robert K Pelz

1 reference

3 December 2017

Pamela A Lipsett

1 reference

3 December 2017

Sandra M Swoboda

1 reference

3 December 2017

Michael G Rinaldi

1 reference

3 December 2017

Craig W Hendrix

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

592-602

1 reference

Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Pharmacokinetics of fluconazole in people with HIV infection: a population analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Pharmacokinetics of antibiotics in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Enteral fluconazole is well absorbed in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Bioavailability of fluconazole in surgical intensive care unit patients: a study comparing routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Effect of fluconazole on the disposition of phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Fluconazole: interspecies scaling and allometric relationships of pharmacokinetic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.5.592.32202

10.1592/PHCO.23.5.592.32202

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference